Browsing Tag
Euronext Paris
22 posts
Ipsen agrees €700m Memo Therapeutics deal as acquisition spree accelerates
Ipsen agrees a €700 million Memo Therapeutics deal days after Kartos. Read how the acquisitions reshape its rare-disease pipeline and cash strategy now.
Alstom wins €800m AMECA locomotive order as execution pressure stays in focus
Alstom booked an €800 million AMECA locomotive order. Explore the backlog boost, execution risks and what investors should watch next.
Safran (EPA: SAF) enters exclusive talks to acquire Exail Technologies in €2.24bn naval drone deal
Safran bids for Exail Technologies in a €2.24 billion sea drone deal. Explore its valuation, financing risks and European defense impact. Read the analysis.
How Airbus’s hybrid-work dispute could affect aircraft deliveries and engineering jobs
Why did Airbus unions protest its four-day office mandate? Explore jet delivery pressure, hybrid work, employee risks and investor implications in Europe.
SEGRO stock jumps 17% as Prologis bid tests SGRO value (LSE)
Prologis offered £12.6bn, but SEGRO says its data-centre future is worth more. The July 22 deadline now tests whether 925p was only an opening bid.
Abivax (NASDAQ: ABVX) obefazimod NDA path meets a safety debate the market is still pricing
Abivax (NASDAQ: ABVX) put up Rinvoq-like ulcerative colitis remission data and dropped 40 percent. The question is whether the malignancy debate sticks.
Edenred (EDEN) shares surge as BC Partners reportedly weighs takeover of French benefits group
Edenred shares surged on reported BC Partners takeover interest. See what regulation, cash flow and valuation mean for EDEN investors.
Alstom wins €300m share of Egypt rail contracts as ALO faces execution test
Find out how Alstom’s €300m share of Egypt rail contracts affects ALO stock, its €104bn backlog and concerns over project execution.
Why Veolia just paid $3bn to double down on America’s most permit-locked industry
Veolia closes its $3.04bn Clean Earth deal to become the number two US hazardous waste player. The synergy math and integration test start now. Read more.
Why Euronext’s Deutsche Boerse merger denial exposes Europe’s market infrastructure dilemma
Euronext says no to Deutsche Boerse for now. See why Europe’s exchange consolidation problem remains unresolved.